Purchases and Sales Made in Q4 2022 in Hillstream Bio Pharma Inc. (HILS)
This table provides information about the institutional ownership of Hillstream Bio Pharma Inc. (HILS) during Q4 2022. The information is specifically focused on institutions that hold shares of Hillstream BioPharma Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
26.2KNew |
$8.38K - $16K
|
26.2K
$75.5K
|
|
|
Feb 14, 2023
Q4 2022
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
21.4KNew |
$6.83K - $13K
|
21.4K
$61.5K
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
BUY
|
- |
702+ 6.54% |
$225 - $428
|
11.4K
$32.9K
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
519+ 6.08% |
$166 - $317
|
9.05K
$26.1K
|
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1+ 3.33% |
$0.32 - $0.61
|
31
$89.3
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-31.8K- 72.2% |
$10.2K - $19.4K
|
12.3K
$35.3K
|